Ghosn M, Dagher E, Nasr F, Chahine G, Taleb N, Nasnas R, Ghayad E
Service d'Hématologie-Oncologie, Hôtel-Dieu de France, Beyrouth, Liban.
J Med Liban. 1994;42(3):117-22.
A total of 59 febrile neutropenic episodes were retrospectively recorded at Hôtel-Dieu de France Hospital between August 1st 1991 and December 31st 1992. These episodes were recorded in 51 cancer patients. Median neutropenia was less than one week in 50% of the cases. The etiology of these fever was documented in 27 episodes (46%) and in 70% of the cases gram (-) rods were documented. B-Lactam and Aminoglycoside antibiotics were used in 34 episodes at the initial treatment of these patients. Success rate at this initial treatment or with a modification of the antibiotic therapy was recorded in 85% of the patients. Only 15% of the patients failed to this antibiotherapy, 2/3 of them had their disease in progression. The systemic use of Amphotericine E in those patients with prolonged febrile neutropenia and the concommitent use of growth factors in a sub-group of patients at high risk could lead to a higher success rate in these patients.
1991年8月1日至1992年12月31日期间,法国主宫医院共回顾性记录了59例发热性中性粒细胞减少症发作病例。这些发作病例记录在51例癌症患者中。50%的病例中性粒细胞减少症的持续时间中位数少于一周。这些发热病例中有27例(46%)记录了病因,70%的病例记录到革兰氏阴性菌。在这些患者的初始治疗中,34例使用了β-内酰胺类和氨基糖苷类抗生素。85%的患者记录了初始治疗或抗生素治疗调整后的成功率。只有15%的患者对抗生素治疗无效,其中2/3的患者病情进展。对于发热性中性粒细胞减少症持续时间较长的患者全身使用两性霉素E,以及在高危亚组患者中同时使用生长因子,可能会使这些患者的成功率更高。